7,044 research outputs found
Recommended from our members
Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma.
Extensive genome-wide analyses of deregulated gene expression have now been performed for many types of cancer. However, most studies have focused on deregulation at the gene-level, which may overlook the alterations of specific transcripts for a given gene. Clear cell renal cell carcinoma (ccRCC) is one of the best-characterized and most pervasive renal cancers, and ccRCCs are well-documented to have aberrant RNA processing. In the present study, we examine the extent of aberrant isoform-specific RNA expression by reporting a comprehensive transcript-level analysis, using the new kallisto-sleuth-RATs pipeline, investigating coding and non-coding differential transcript expression in ccRCC. We analyzed 50 ccRCC tumors and their matched normal samples from The Cancer Genome Altas datasets. We identified 7,339 differentially expressed transcripts and 94 genes exhibiting differential transcript isoform usage in ccRCC. Additionally, transcript-level coexpression network analyses identified vasculature development and the tricarboxylic acid cycle as the most significantly deregulated networks correlating with ccRCC progression. These analyses uncovered several uncharacterized transcripts, including lncRNAs FGD5-AS1 and AL035661.1, as potential regulators of the tricarboxylic acid cycle associated with ccRCC progression. As ccRCC still presents treatment challenges, our results provide a new resource of potential therapeutics targets and highlight the importance of exploring alternative methodologies in transcriptome-wide studies
Recommended from our members
FreePSI: an alignment-free approach to estimating exon-inclusion ratios without a reference transcriptome.
Alternative splicing plays an important role in many cellular processes of eukaryotic organisms. The exon-inclusion ratio, also known as percent spliced in, is often regarded as one of the most effective measures of alternative splicing events. The existing methods for estimating exon-inclusion ratios at the genome scale all require the existence of a reference transcriptome. In this paper, we propose an alignment-free method, FreePSI, to perform genome-wide estimation of exon-inclusion ratios from RNA-Seq data without relying on the guidance of a reference transcriptome. It uses a novel probabilistic generative model based on k-mer profiles to quantify the exon-inclusion ratios at the genome scale and an efficient expectation-maximization algorithm based on a divide-and-conquer strategy and ultrafast conjugate gradient projection descent method to solve the model. We compare FreePSI with the existing methods on simulated and real RNA-seq data in terms of both accuracy and efficiency and show that it is able to achieve very good performance even though a reference transcriptome is not provided. Our results suggest that FreePSI may have important applications in performing alternative splicing analysis for organisms that do not have quality reference transcriptomes. FreePSI is implemented in C++ and freely available to the public on GitHub
Recommended from our members
The Expanding Landscape of Alternative Splicing Variation in Human Populations.
Alternative splicing is a tightly regulated biological process by which the number of gene products for any given gene can be greatly expanded. Genomic variants in splicing regulatory sequences can disrupt splicing and cause disease. Recent developments in sequencing technologies and computational biology have allowed researchers to investigate alternative splicing at an unprecedented scale and resolution. Population-scale transcriptome studies have revealed many naturally occurring genetic variants that modulate alternative splicing and consequently influence phenotypic variability and disease susceptibility in human populations. Innovations in experimental and computational tools such as massively parallel reporter assays and deep learning have enabled the rapid screening of genomic variants for their causal impacts on splicing. In this review, we describe technological advances that have greatly increased the speed and scale at which discoveries are made about the genetic variation of alternative splicing. We summarize major findings from population transcriptomic studies of alternative splicing and discuss the implications of these findings for human genetics and medicine
NOVEL COMPUTATIONAL METHODS FOR TRANSCRIPT RECONSTRUCTION AND QUANTIFICATION USING RNA-SEQ DATA
The advent of RNA-seq technologies provides an unprecedented opportunity to precisely profile the mRNA transcriptome of a specific cell population. It helps reveal the characteristics of the cell under the particular condition such as a disease. It is now possible to discover mRNA transcripts not cataloged in existing database, in addition to assessing the identities and quantities of the known transcripts in a given sample or cell. However, the sequence reads obtained from an RNA-seq experiment is only a short fragment of the original transcript. How to recapitulate the mRNA transcriptome from short RNA-seq reads remains a challenging problem. We have proposed two methods directly addressing this challenge. First, we developed a novel method MultiSplice to accurately estimate the abundance of the well-annotated transcripts. Driven by the desire of detecting novel isoforms, a max-flow-min-cost algorithm named Astroid is designed for simultaneously discovering the presence and quantities of all possible transcripts in the transcriptome. We further extend an \emph{ab initio} pipeline of transcriptome analysis to large-scale dataset which may contain hundreds of samples. The effectiveness of proposed methods has been supported by a series of simulation studies, and their application on real datasets suggesting a promising opportunity in reconstructing mRNA transcriptome which is critical for revealing variations among cells (e.g. disease vs. normal)
MSIQ: Joint Modeling of Multiple RNA-seq Samples for Accurate Isoform Quantification
Next-generation RNA sequencing (RNA-seq) technology has been widely used to
assess full-length RNA isoform abundance in a high-throughput manner. RNA-seq
data offer insight into gene expression levels and transcriptome structures,
enabling us to better understand the regulation of gene expression and
fundamental biological processes. Accurate isoform quantification from RNA-seq
data is challenging due to the information loss in sequencing experiments. A
recent accumulation of multiple RNA-seq data sets from the same tissue or cell
type provides new opportunities to improve the accuracy of isoform
quantification. However, existing statistical or computational methods for
multiple RNA-seq samples either pool the samples into one sample or assign
equal weights to the samples when estimating isoform abundance. These methods
ignore the possible heterogeneity in the quality of different samples and could
result in biased and unrobust estimates. In this article, we develop a method,
which we call "joint modeling of multiple RNA-seq samples for accurate isoform
quantification" (MSIQ), for more accurate and robust isoform quantification by
integrating multiple RNA-seq samples under a Bayesian framework. Our method
aims to (1) identify a consistent group of samples with homogeneous quality and
(2) improve isoform quantification accuracy by jointly modeling multiple
RNA-seq samples by allowing for higher weights on the consistent group. We show
that MSIQ provides a consistent estimator of isoform abundance, and we
demonstrate the accuracy and effectiveness of MSIQ compared with alternative
methods through simulation studies on D. melanogaster genes. We justify MSIQ's
advantages over existing approaches via application studies on real RNA-seq
data from human embryonic stem cells, brain tissues, and the HepG2 immortalized
cell line
Bayesian Modeling Approaches for Temporal Dynamics in RNA-seq Data
Analysis of differential expression has been a central role to address the variety of biological questions in the manner to characterize abnormal patterns of cellular and molecular functions for last decades. To date, identification of differentially expressed genes and isoforms has been more intensively focused on temporal dynamics over a series of time points. Bayesian strategies have been successfully employed to uncover the complexity of biological interest with the methodological and analytical perspectives for the various platforms of high-throughput data, for instance, methods in differential expression analysis and network modules in transcriptome data, peak-callers in ChipSeq data, target prediction in microRNA data and meta-methods between different platforms. In this chapter, we will discuss how our methodological works based on Bayesian models address important questions to arise in the architecture of temporal dynamics in RNA-seq data
- …